Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changes from v3.8.0 to v3.8.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-22T02:35:52.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The record describes a Phase 2 study of PD-1 antibody combined with a COX inhibitor for colorectal cancer and provides details for prospective participants, including eligibility, recruiting locations, and study measures.
    Difference
    49%
    Check dated 2026-11-08T05:25:12.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.2 to v3.8.0; the study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:30:45.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The page displays details for a phase 2 study of PD-1 antibody combined with a COX inhibitor for colorectal cancer, including its study design, eligibility criteria, recruiting locations, and outcome measures.
    Difference
    51%
    Check dated 2026-10-25T02:31:31.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T02:15:27.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T03:22:19.000Z thumbnail image

Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.